New sources of pancreatic β-cells

Nature Biotechnology

Volumn 23, Issue 7, 2005, Pages 857-861

  Bonner Weir, Susan ^a   Weir, Gordon C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; DISEASES; GLUCOSE; POLYPEPTIDES;

EPIDERMAL GROWTH FACTOR; GLUCAGON; PANCREAS;

CELLS;

EPIDERMAL GROWTH FACTOR; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GASTRIN; GLUCAGON; PEPTIDE; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; VENOM;

ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL REGENERATION; EMBRYONIC STEM CELL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; CYTOLOGY; DIABETES MELLITUS; DRUG EFFECT; EMBRYO; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY; REGENERATION; REVIEW; STEM CELL;

CELL DIFFERENTIATION; DIABETES MELLITUS; EMBRYO; EPIDERMAL GROWTH FACTOR; GASTRINS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; ISLETS OF LANGERHANS; PANCREAS; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN PRECURSORS; REGENERATION; STEM CELLS; VENOMS;

EID: 24944591025     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1115     Document Type: Article

References (77)

1. Writing team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290, 2159-2167 (2003).
2. Shapiro, A.M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230-238 (2000).
3. Robertson, R.P. Islet transplantation as a treatment for diabetes-a work in progress. N. Engl. J. Med. 350, 694-705 (2004).
4. Trucco, M. Regeneration of the pancreatic beta cell. J. Clin. Invest. 115, 5-12 (2005).
5. Bonner-Weir, S. Perspective: postnatal pancreatic beta cell growth. Endocrinology 141, 1926-1929 (2000).
6. Tyrberg, B., et al. Stimulated endocrine cell proliferation and differentiation in transplanted human pancreatic islets: effects of the ob gene and compensatory growth of the implantation organ. Diabetes 50, 301-307 (2001).
7. Zulewski, H. et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50, 521-533 (2001).
8. Linning, K.D. et al. Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential. Pancreas 29, e64-e76 (2004).
9. Gershengorn, M.C. et al. Epithelial-to-mesenchymal transition generates proliferate human islet precursor cells. Science 306, 2261-2264 (2004).
10. Lechner, A., Nolan, A.L., Blacken, R.A. & Habener, J.F. Redifferentiation of insulin-secreting cells after in vitro expansion of adult human pancreatic islet tissue. Biochem. Biophys. Res. Commun. 327, 581-588 (2005).
11. Grunert, S., et al. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 4, 657-665 (2003).
12. Ling, Z. & Pipeleers, D.G. Prolonged exposure of human β cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J. Clin. Invest. 98, 2805-2812 (1996).
13. Hardikar, A.A., et al. Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates. Proc. Natl. Acad. Sci. USA 100, 7117-7122 (2003).
14. Soria, B. et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in strepotozotocin-induced diabetic mice. Diabetes 49, 157-162 (2000).
15. Assady, S. et al. Insulin production by human embryonic stem cells. Diabetes 50, 1691-1697 (2001).
16. Leon-Quinto, T., et al. In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 47, 1442-1451 (2004).
17. Lumelsky, N. et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389-1393 (2001).
18. Hori, Y. et al. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc. Natl. Acad. Sci. USA 99, 16105-16110 (2002).
19. Kahan, B.W. et al. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes 52, 2016-2024 (2003).
20. Blyszczuk, P. et al. Embryonic stem cells differentiate into insulin-producing cells without selection of nestin-expressing cells. Int. J. Dev. Biol. 48, 1095-1104 (2004).
21. Blyszczuk, P. et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc. Natl. Acad. Sci. USA 100, 998-1003 (2003).
22. Miyazaki, S., Yamato, E. & Miyazaki, J. Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes 53, 1030-1037 (2004).
23. Segev, H., et al. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 22, 265-274 (2004).
24. Rajagopal, J., Anderson, W.J., Kume, S., Martinez, O.I. & Melton, D.A. Insulin staining of ES cell progeny from insulin uptake. Science 299, 363 (2003).
25. Hansson, M. et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes 53, 2603-2609 (2004).
26. Sipione, S., et al. Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia 47, 499-508 (2004).
27. Kania, G., et al. The generation of insulin-producing cells from embryonic stem cells - a discussion of controversial findings. Int. J. Dev. Biol. 48, 1061-1064 (2004).
28. Hori, Y., Gu, X., Xie, X. & Kim, S.K. Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med. 2, e103 (2005).
29. Schuit, F., et al. Glucose-regulated gene expression maintaining the glucose-responsive state of beta-cells. Diabetes (suppl. 3) 51, S326-S332 (2002).
30. Halban, P. A., et al. Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes 50, 2181-2191 (2001).
31. Weir, G.C. Can we make surrogate beta-cells better than the original? Semin. Cell Dev. Biol. 15, 347-357 (2004).
32. Hanahan, D. Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr. Opin. Immunol. 10, 656-662 (1998).
33. Devaskar, S.U. et al. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J. Biol. Chem. 269, 8445-8454 (1994).
34. Alarcon, C., et al. Synthesis and differentially regulated processing of proinsulin in developing chick pancreas, liver and neuroretina. FEBS Lett. 436, 361-366 (1998).
35. Asahina, K. et al. Expression of the liver-specific gene Cyp7a1 reveals hepatic differentiation in embryoid bodies derived from mouse embryonic stem cells. Genes Cells 9, 1297-1308 (2004).
36. Kubo, A. et al. Development of definitive endoderm from embryonic stem cells in culture. Development 131, 1651-1662 (2004).
37. Ku, H.T. et al. Committing embryonic stem cells to early endocrine pancreas in vitro. Stem Cells 22, 1205-1217 (2004).
38. Dor, Y., Brown, J., Martinez, O.I. & Melton, D.A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41-46 (2004).
39. Suzuki, A., Nakauchi, H. & Taniguchi, H. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes 53, 2143-2152 (2004).
40. Seaberg, R.M. et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol. 22, 1115-1124 (2004).
41. Weir, G.C. & Bonner-Weir, S. Beta-cell precursors - a work in progress. Nat. Biotechnol. 22, 1095-1096 (2004).
42. Bonner-Weir, S. et al. The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr. Diabetes 5, 16-22 (2004).
43. Lardon, J., Huyens, N., Rooman, I. & Bouwens, L. Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas. Virchows Arch. 444, 61-65 (2004).
44. Baeyens, L. et al. In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 48, 49-57 (2005).
45. Rooman, I., et al. Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas. Gastroenterology 121, 940-949 (2001).
46. Rooman, I. & Bouwens, L. Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57BI6/J mice treated with alloxan. Diabetologia 47, 259-265 (2004).
47. Jensen, J.N. et al. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology 128, 728-741 (2005).
48. Bonner-Weir, S. et al. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA 97, 7999-8004 (2000).
49. Gao, R. et al. Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 52, 2007-2015 (2003).
50. Suarez-Pinzon, W.L., et al. Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet β-cells from pancreatic duct cells and an increase in functional β-cell mass. J. Clin. Endocrinol. Metab. 90, 3401-3409 (2005).
51. Jiang, Y. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 (2002).
52. Ianus, A., Holz, G.G., Theise, N.D. & Hussain, M.A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. 111, 843-850 (2003).
53. Hess, D. et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21, 763-770 (2003).
54. Mathews, V. et al. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 53, 91-98 (2004).
55. Tang, D.Q. et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 53, 1721-1732 (2004).
56. Zorina, T.D. et al. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 21, 377-388 (2003).
57. Kodama, S., et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302, 1223-1227 (2003).
58. Ogawa, N., et al. Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 53, 1700-1705 (2004).
59. Chatenoud, L., Primo, J. & Bach, J.F. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol. 158, 2947-2954 (1997).
60. Fujita, Y., Cheung, A.T. & Kieffer, T.J. Harnessing the gut to treat diabetes. Pediatr. Diabetes (suppl. 2) 5, 57-69 (2004).
61. Ferber, S. et al. Pancreatic and duodenal homeoboxgene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med. 6, 568-572 (2000).
62. Ber, I. et al. Functional, persistent, and extended liver to pancreas transdifferentiation. J. Biol. Chem. 278, 31950-31957 (2003).
63. Kaneto, H. et al. A crucial role of mafA as a novel therapeutic target for diabetes. J. Biol. Chem. 280, 15047-15052 (2005).
64. Kojima, H. et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat. Med. 9, 596-603 (2003).
65. Zalzman, M. et al. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc. Natl. Acad. Sci. USA 100, 7253-7258 (2003).
66. Kaneto, H. et al. PDX-1/VP16 fusion protein, together with neuroD or ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance. Diabetes 54, 1009-1022 (2005).
67. Yang, L. et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Natl. Acad. Sci. USA 99, 8078-8083 (2002).
68. Cao, L.Z., Tang, D.Q., Horb, M.E., Li, S.W. & Yang, L.J. High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells. Diabetes 53, 3168-3178 (2004).
69. Bruning, J.C. et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561-572 (1997).
70. Butler, A.E. et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110 (2003).
71. Rosenberg, L. et al. A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. Ann. Surg. 240, 875-884 (2004).
72. Li, L., et al. Activin A and betacellulin: effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. Diabetes 53, 608-615 (2004).
73. Brubaker, P.L. & Drucker, D.J. Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145, 2653-2659 (2004).
74. DeFronzo, R.A., et al. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 28, 1092-1100 (2005).
75. Kendall, D.M. et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 28, 1083-1091 (2005).
76. Ratner, R.E., Feeley, D., Buse, J.B. & Schwartz, S.L. Double-blind, placebo-controlled trial of islet neogenesis gene associated protein (INGAP) in type 1 diabetes. Diabetes (suppl. 1) 54, 11-LB (late breaking abstract) (2005).
77. Ratner, R.E., Feeley, D., Buse, J.B. & Fischer, J.S. Double-blind, placebo-controlled trial of islet neogenesis gene associated protein (INGAP) in type 2 diabetes. Diabetes (suppl. 1) 54, 12-LB (late breaking abstract) (2005).